Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iranzo

Showing results (561-570 of 735) with videos related to

Pageof 74
Sort By:
Molecular Neurodegeneration|February 11, 2025
From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related diseaseAmbra Stefani, Elena Antelmi, Dario Arnaldi, et al.
The Lancet. Neurology|February 20, 2021
Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational studyAlex Iranzo, Graham Fairfoul, Anutra Chumbala Na Ayudhaya, et al.
Nature Structural & Molecular Biology|January 4, 2024
DNA methylation restricts coordinated germline and neural fates in embryonic stem cell differentiationMathieu Schulz, Aurélie Teissandier, Elena De La Mata Santaella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2014
Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorderAlex Iranzo, Heike Stockner, Mónica Serradell, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|September 11, 2003
[Literature review on the stability of diluted mixtures of cytostatic agents]M C Matoses Chirivella, J León Villar, J M Arrieta Garmendia, et al.
Sleep|February 10, 2018
The distinguishing motor features of cataplexy: a study from video-recorded attacksFabio Pizza, Elena Antelmi, Stefano Vandi, et al.
Investigational New Drugs|October 1, 2013
Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD studyM Martin-Richard, R Gallego, C Pericay, et al.
Neuro-Degenerative Diseases|November 13, 2015
Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive ImpairmentAlba Sierra-Rio, Mircea Balasa, Jaume Olives, et al.
European Journal of Neurology|May 18, 2013
Decreased striatal dopamine transporter uptake in the non-fluent/agrammatic variant of primary progressive aphasiaS Gil-Navarro, F Lomeña, A Cot, et al.
The Lancet. Neurology|April 8, 2014
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem studyLidia Sabater, Carles Gaig, Ellen Gelpi, et al.
Pageof 74

Showing results (561-570 of 735) with videos related to

Sort By:
Pageof 74
Molecular Neurodegeneration|February 11, 2025
From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related diseaseAmbra Stefani, Elena Antelmi, Dario Arnaldi, et al.
The Lancet. Neurology|February 20, 2021
Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational studyAlex Iranzo, Graham Fairfoul, Anutra Chumbala Na Ayudhaya, et al.
Nature Structural & Molecular Biology|January 4, 2024
DNA methylation restricts coordinated germline and neural fates in embryonic stem cell differentiationMathieu Schulz, Aurélie Teissandier, Elena De La Mata Santaella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2014
Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorderAlex Iranzo, Heike Stockner, Mónica Serradell, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|September 11, 2003
[Literature review on the stability of diluted mixtures of cytostatic agents]M C Matoses Chirivella, J León Villar, J M Arrieta Garmendia, et al.
Sleep|February 10, 2018
The distinguishing motor features of cataplexy: a study from video-recorded attacksFabio Pizza, Elena Antelmi, Stefano Vandi, et al.
Investigational New Drugs|October 1, 2013
Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD studyM Martin-Richard, R Gallego, C Pericay, et al.
Neuro-Degenerative Diseases|November 13, 2015
Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive ImpairmentAlba Sierra-Rio, Mircea Balasa, Jaume Olives, et al.
European Journal of Neurology|May 18, 2013
Decreased striatal dopamine transporter uptake in the non-fluent/agrammatic variant of primary progressive aphasiaS Gil-Navarro, F Lomeña, A Cot, et al.
The Lancet. Neurology|April 8, 2014
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem studyLidia Sabater, Carles Gaig, Ellen Gelpi, et al.
Pageof 74